Fedratinib 100mg, 200mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 100mg, 200mg
Reference Brands: Inrebic (USA/EU)
Category: Oncology Cancer Care
Fedratinib is an oral JAK2 inhibitor used for the treatment of adults with intermediate-2 or high-risk primary or secondary myelofibrosis. It helps reduce spleen size and improves disease-related symptoms by selectively targeting the JAK2 pathway involved in abnormal blood cell production.
Fedratinib — third party manufacturing & bulk supply
Fedratinib 100mg, 200mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Fedratinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Fedratinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Fedratinib is used for treating intermediate-2 or high-risk primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis. It works as a selective JAK2 inhibitor that helps reduce spleen size and improve associated disease symptoms.
Fedratinib is made from the active ingredient fedratinib hydrochloride, a targeted small-molecule JAK2 inhibitor designed to block dysregulated signaling involved in myeloproliferative disorders.
The trade name is Inrebic.
Inrebic is manufactured and marketed by Celgene, which is now a part of Bristol-Myers Squibb (BMS).
The generic name is fedratinib hydrochloride.
The brand name is Inrebic.
Fedratinib is manufactured in the United States and Europe under Bristol-Myers Squibb’s regulated production facilities.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
